These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 22791522)
1. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study. Colombo S; Leone F; Vercelli A; Cornegliani L Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522 [TBL] [Abstract][Full Text] [Related]
2. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare). Mueller RS; Meyer D; Bensignor E; Sauter-Louis C Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482 [TBL] [Abstract][Full Text] [Related]
3. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin. Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483 [TBL] [Abstract][Full Text] [Related]
4. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes. Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Heine J; Krieger K; Dumont P; Hellmann K Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281 [TBL] [Abstract][Full Text] [Related]
6. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid. Huang HP; Lien YH Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study. Krieger K; Heine J; Dumont P; Hellmann K Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs. Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs. Loft KE; Willesen JL Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103 [No Abstract] [Full Text] [Related]
10. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis. Fourie JJ; Meyer L; Thomas E Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Beugnet F; Halos L; Larsen D; de Vos C Parasite; 2016; 23():14. PubMed ID: 27012161 [TBL] [Abstract][Full Text] [Related]
13. An update on the therapy of canine demodicosis. Mueller RS Compend Contin Educ Vet; 2012 Apr; 34(4):E1-4. PubMed ID: 22488596 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats. Fourie LJ; Kok DJ; Heine J Parasitol Res; 2003 Jul; 90 Suppl 3():S112-3. PubMed ID: 12928871 [No Abstract] [Full Text] [Related]
15. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs. Fourie LJ; Du Rand C; Heine J Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866). Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583 [TBL] [Abstract][Full Text] [Related]
17. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs. Arther RG; Bowman DD; Slone RL; Travis LE Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279 [TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Demodex gatoi with 10% Imidacloprid/1% Moxidectin. Short J; Gram D J Am Anim Hosp Assoc; 2016; 52(1):68-72. PubMed ID: 26606209 [TBL] [Abstract][Full Text] [Related]
19. Dermal safety study with imidacloprid/moxidectin topical solution in the ivermectin-sensitive collie. Paul AJ; Hutchens DE; Firkins LD; Borgstrom M Vet Parasitol; 2004 May; 121(3-4):285-91. PubMed ID: 15135868 [TBL] [Abstract][Full Text] [Related]
20. A European field assessment of the efficacy of fluralaner (Bravecto Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]